Health

Invivyd Announces Closing of $57.5 Million Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares

August 22, 2025 12:00 ET  | Source: Invivyd WALTHAM, Mass., Aug. 22, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Invivyd) (Nasdaq:…

10 months ago

Tevogen Recognized in BINJEs BEST Health Care 2025 for Advancing Health Equity and Sustainable Biopharma

WARREN, N.J., Aug. 22, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or the “Company”) (Nasdaq: TVGN), announced today…

10 months ago

Branded Legacy, Inc. Forms Strategic Partnership with Stanford University’s Dr. Eran Bendavid to Advance Addiction Solutions

VANCOUVER, British Columbia, Aug. 22, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. (OTC: BLEG), a leading diversified…

10 months ago

Des pas en alimentation durable mais trop petits pour bien nourrir tout le Qubec

Dévoilement de la politique bioalimentaire 2025-2035 August 22, 2025 12:52 ET  | Source: Collectif Vital MONTRÉAL, Aug. 22, 2025 (GLOBE…

10 months ago

Celularity Receives Nasdaq Notice Regarding Form 10-Q

August 22, 2025 17:30 ET  | Source: Celularity, Inc. FLORHAM PARK, N.J., Aug. 22, 2025 (GLOBE NEWSWIRE) -- Celularity Inc.…

10 months ago

Aptose Biosciences Announces Results of Reconvened Annual and Special Shareholders Meeting and Appointment of Ernst & Young LLP as New Auditor

SAN DIEGO and TORONTO, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC:…

10 months ago

MEDIROM launches cryptocurrency strategy with next-generation proof of human technology, “World”

TOKYO, Aug. 22, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; CEO: Kouji Eguchi; NASDAQ: MRM) (the…

10 months ago

Financire de Tubize – Convening of the extraordinary general meeting of shareholders of Sep. 24, 2025

August 22, 2025 02:00 ET  | Source: Financière de Tubize SA Convening of the Extraordinary General Meeting of shareholders of…

10 months ago

Bavarian Nordic Announces First Half 2025 Results

COPENHAGEN, Denmark, August 22, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress…

10 months ago

Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters Over-Allotment Option

SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage…

10 months ago